Stock MRAI MARPAI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Marpai, Inc. Stock

Equities

MRAI

US5713542083

Software

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-02 EDT 		5-day change 1st Jan Change
2.434 USD +16.46% Intraday chart for Marpai, Inc. +14.28% +39.09%
04-24 Marpai, Inc. Announces Executive Appointments CI
04-16 Marpai, Inc. announced that it has received $11.83 million in funding from JGB Management Inc. CI

Financials

Sales 2024 * 38.54M 52.67M Sales 2025 * 75.1M 103M Capitalization 25.07M 34.26M
Net income 2024 * -17M -23.23M Net income 2025 * -7M -9.57M EV / Sales 2024 * 0.65 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.33 x
P/E ratio 2024 *
-1.48 x
P/E ratio 2025 *
-3.93 x
Employees 162
Yield 2024 *
-
Yield 2025 *
-
Free-Float 38.9%
More Fundamentals * Assessed data

Chart Marpai, Inc.

Dynamic Chart

Latest news about Marpai, Inc.

Marpai, Inc. Announces Executive Appointments CI
Marpai, Inc. announced that it has received $11.83 million in funding from JGB Management Inc. CI
Maxim Upgrades Marpai to Buy From Hold, Price Target is $6 MT
Transcript : Marpai, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Marpai, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Marpai Insider Bought Shares Worth $1,501,500, According to a Recent SEC Filing MT
Marpai, Inc. announced that it expects to receive $1.5015 million in funding CI
Marpai, Inc. Provides Impairment Guidance for the Fourth Quarter of 2023 CI
Marpai, Inc. Announces Off-Cycle New Client Agreement CI
Marpai, Inc. announced that it has received $1.7 million in funding from Libertas Funding, LLC CI
Top Premarket Gainers MT
Marpai Insider Bought Shares Worth $1,012,110, According to a Recent SEC Filing MT
Marpai, Inc. announced that it expects to receive $1.216464 million in funding CI
Marpai, Inc. Appoints John Powers as President CI
PayFlex Systems USA, Inc. acquired Maestro Health Consumer Directed Benefits Business of Marpai, Inc.. CI
More news

Latest transcript on Marpai, Inc.

Logo Marpai, Inc.
Marpai, Inc., Q4 2023 Earnings Call, Mar 27, 2024
More transcripts

Analyst Recommendations on Marpai, Inc.

Maxim Upgrades Marpai to Buy From Hold, Price Target is $6 MT
Maxim Downgrades Marpai to Hold From Buy MT
Maxim Initiates Marpai at Buy With $2.50 Price Target MT
More recommendations

Press releases Marpai, Inc.

MARPAI INC. ANNOUNCES COST REDUCTION PROGRAM AND PROPERTY SUBLEASE PR
MARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVES PR
MARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTES PR
MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS PR
NASDAQ PANEL GRANTS MARPAI'S REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING REQUIREMENTS PR
More press releases

Quotes and Performance

1 day+16.46%
1 week+14.28%
Current month+19.91%
1 month-13.38%
3 months+109.84%
6 months+504.00%
Current year+39.09%
More quotes

Highs and lows

1 week
1.99
Extreme 1.9942
2.47
1 month
1.75
Extreme 1.7506
2.65
Current year
0.82
Extreme 0.8195
2.97
1 year
0.33
Extreme 0.33
3.46
3 years
0.33
Extreme 0.33
25.24
5 years
0.33
Extreme 0.33
25.24
10 years
0.33
Extreme 0.33
25.24
More quotes

Managers and Directors - Marpai, Inc.

Managers TitleAgeSince
Damien Lamendola CEO
 Chief Executive Officer 68 21-03-31
Eli David FOU
 Founder - 19-05-31
Steve Johnson DFI
 Director of Finance/CFO 54 11-05
Members of the board TitleAgeSince
Sagiv Shiv BRD
 Director/Board Member 67 23-01-31
Robert Pons BRD
 Director/Board Member 68 12-06
Yaron Eitan FOU
 Founder 67 21-03-31
More insiders

Quotes

Date Price Change Volume
24-05-02 2.434 +16.46% 202,461
24-05-01 2.09 +2.96% 213,924
24-04-30 2.03 -1.93% 103,534
24-04-29 2.07 -5.05% 97,730
24-04-26 2.18 +2.35% 45,685

Delayed Quote Nasdaq, May 02, 2024 at 04:30 pm

More quotes

Company Profile

Marpai, Inc. is a technology-driven healthcare company, which uses artificial intelligence (AI) and data analytics. The Company provides administrative services and acts as a third-party administrator (TPA) to self-insured employers who provide healthcare benefits to their employees. Its products and services include Health Plan Administration services, Ancillary In-House services, and Third-Party Vendor services. Its Health Plan Administration services offering includes handling all aspects of administration related to a healthcare plan. Its In-House Ancillary Services are derived from its in-house products related to its role as the administrator of the clients' health plans. The Company typically design healthcare benefit plan for its client, which allows the client to define the coverage it would like to provide to its employees. The Company offers MarpaiRx, a national pharmacy benefit management program.
Sector
Software
Calendar
2024-05-06 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Ratings for Marpai, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.434 USD
Average target price
6 USD
Spread / Average Target
+146.50%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

1st Jan change Capi.
MARPAI, INC. Stock Marpai, Inc.
+39.09% 25.07M
MICROSOFT CORPORATION Stock Microsoft Corporation
+5.80% 2,957B
SYNOPSYS INC. Stock Synopsys Inc.
+1.64% 79.84B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+1.50% 75.23B
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-17.06% 51.63B
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+31.33% 50.22B
ATLASSIAN CORPORATION Stock Atlassian Corporation
-22.83% 47.78B
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+22.46% 43.07B
SEA LIMITED Stock Sea Limited
+57.98% 36.75B
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
-11.11% 24.41B
Other Software
  1. Stock Market
  2. Equities
  3. MRAI Stock